Nonstatin Therapy Updates for Lipid Management
The session will review the novel medications bempedoic acid and inclisiran for LDL reduction, as well as the evidence to support the use of these agents. A review of the treatment pathways and recommendations from recent guidelines that include these agents will be conducted, as well as a brief discussion of the place of therapy these agents have compared to the current standards of care.
Learning Objectives
At the completion of this activity, the participant should be able to:
- Explain the new non-statin lipid-lowering agents with the evidence on cardiovascular outcomes of non-statin lipid-lowering agents in recent clinical trials.
- Describe the current recommendations from the clinical practice guidelines in the management of atherosclerotic cardiovascular disease (ASCVD) risk.
- Choose an appropriate evidence-based treatment option for patients to optimize the risk management of ASCVD
Presenter
Nicole Camasura, PharmD, is a recent graduate of the University of Saint Joseph School of Pharmacy, where she was an active member with the American College of Clinical Pharmacy and Rho Chi Honor Society. She is currently a PGY-1 Pharmacy Resident at Mount Auburn Hospital in Cambridge, MA. Her current areas of interest include internal medicine, ambulatory care, and outpatient oncology.
Course Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.
Release Date: April 17, 2024
Expiration Date: April 17, 2025
ACPE UAN: 0026-0000-24-011-H01-P | Application
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1 (0.1 CEU)
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).
In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Nicole Camasura, PharmD, has no financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry provided for this event. No exhibitors will be present